GlassScriptPhysician profile
Miriam Greene
NPI 1679618904
$6,330.49
in general payments reported to CMS, 2019-2025
23 companies · $693 in 2025
The $693 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,310 · 2020: $564 · 2021: $593 · 2022: $502 · 2023: $802 · 2024: $866 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,029 · Education: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,029.04 |
| Education | $332.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,027.02 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $1,004.44 | 2019-2020 | |
| Abbvie INC. | $965.11 | 2019-2023 | |
| Astellas Pharma US INC | $819.70 | 2019-2025 | Veozah, Myrbetriq |
| Therapeuticsmd, INC. | $585.74 | 2019-2022 | |
| Amgen INC. | $442.13 | 2019-2025 | Evenity |
| Millicent US INC | $336.07 | 2019-2025 | Intrarosa |
| Myovant Sciences INC. | $185.60 | 2021-2022 | |
| Glaxosmithkline, LLC. | $169.15 | 2020-2022 | |
| Duchesnay USA Incorporated | $165.74 | 2019 | |
| Medtronic, INC. | $130.20 | 2024 | Truclear |
| Roche Diagnostics Corporation | $117.40 | 2019 | |
| Sumitomo Pharma America, INC. | $61.90 | 2025 | Gemtesa, Myfembree |
| Radius Health, INC. | $59.30 | 2024-2025 | Tymlos, Binosto |
| Avion Pharmaceuticals | $56.78 | 2021-2023 | Balcoltra |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Currax Pharmaceuticals LLC | $45.99 | 2024 | Contrave |
| Urovant Sciences INC | $36.70 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $29.82 | 2019-2021 | |
| Exact Sciences Corporation | $27.70 | 2025 | The Cologuard Plus Collection Kit |
| Cosette Pharmaceuticals INC. | $19.14 | 2024 | Vyleesi |
| Allergan, INC. | $15.63 | 2020 | |
| Hologic Sales and Service, LLC | $15.61 | 2024 | Aptima |
| Vertical Pharmaceuticals, LLC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.